Annual CFF
$17.34 M
+$14.40 M+490.73%
December 1, 2024
Summary
- As of March 12, 2025, CMPX annual cash flow from financing activities is $17.34 million, with the most recent change of +$14.40 million (+490.73%) on December 1, 2024.
- During the last 3 years, CMPX annual CFF has fallen by -$101.27 million (-85.38%).
- CMPX annual CFF is now -85.38% below its all-time high of $118.61 million, reached on December 31, 2021.
Performance
CMPX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$94.00 K
-$92.00 K-4600.00%
December 1, 2024
Summary
- As of March 12, 2025, CMPX quarterly cash flow from financing activities is -$94.00 thousand, with the most recent change of -$92.00 thousand (-4600.00%) on December 1, 2024.
- Over the past year, CMPX quarterly CFF has dropped by -$17.53 million (-100.54%).
- CMPX quarterly CFF is now -100.08% below its all-time high of $124.24 million, reached on December 1, 2021.
Performance
CMPX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$17.34 M
+$64.00 K+0.37%
December 1, 2024
Summary
- As of March 12, 2025, CMPX TTM cash flow from financing activities is $17.34 million, with the most recent change of +$64.00 thousand (+0.37%) on December 1, 2024.
- Over the past year, CMPX TTM CFF has dropped by -$2.99 million (-14.70%).
- CMPX TTM CFF is now -86.04% below its all-time high of $124.24 million, reached on September 30, 2022.
Performance
CMPX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CMPX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +490.7% | -100.5% | -14.7% |
| 3 y3 years | -85.4% | -100.5% | -14.7% |
| 5 y5 years | +100.0% | -100.5% | -14.7% |
CMPX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.4% | +490.7% | -100.1% | +40.5% | -86.0% | +490.7% |
| 5 y | 5-year | -85.4% | -100.0% | -100.1% | +96.5% | -86.0% | +308.8% |
| alltime | all time | -85.4% | -100.0% | -100.1% | +96.5% | -86.0% | +308.8% |
Compass Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $17.34 M(+490.7%) | -$94.00 K(+4600.0%) | $17.34 M(+0.4%) |
| Sep 2024 | - | -$2000.00(-300.0%) | $17.27 M(-0.1%) |
| Jun 2024 | - | $1000.00(-100.0%) | $17.30 M(-14.9%) |
| Mar 2024 | - | $17.43 M(<-9900.0%) | $20.33 M(+592.6%) |
| Dec 2023 | $2.94 M(-96.1%) | -$158.00 K(-852.4%) | $2.94 M(-96.3%) |
| Sep 2023 | - | $21.00 K(-99.3%) | $78.84 M(+0.0%) |
| Jun 2023 | - | $3.03 M(+7292.7%) | $78.83 M(+4.0%) |
| Mar 2023 | - | $41.00 K(-99.9%) | $75.80 M(+0.1%) |
| Dec 2022 | $75.76 M | $75.75 M(>+9900.0%) | $75.76 M(-39.0%) |
| Sep 2022 | - | $5000.00(>+9900.0%) | $124.24 M(+1.5%) |
| Jun 2022 | - | $0.00(0.0%) | $122.36 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | $120.49 M(+1.6%) |
| Dec 2021 | $118.61 M(+144.4%) | - | - |
| Dec 2021 | - | $124.24 M(-6725.9%) | $118.61 M(-1681.5%) |
| Sep 2021 | - | -$1.88 M(0.0%) | -$7.50 M(-9.7%) |
| Jun 2021 | - | -$1.88 M(0.0%) | -$8.30 M(-117.8%) |
| Mar 2021 | - | -$1.88 M(0.0%) | $46.66 M(-3.9%) |
| Dec 2020 | $48.54 M(>+9900.0%) | -$1.88 M(-30.0%) | $48.54 M(-3.7%) |
| Sep 2020 | - | -$2.68 M(-105.0%) | $50.41 M(-5.0%) |
| Jun 2020 | - | $53.09 M(>+9900.0%) | $53.09 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00(-100.0%) | - | - |
| Dec 2018 | $64.03 M | - | - |
FAQ
- What is Compass Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Compass Therapeutics?
- What is Compass Therapeutics annual CFF year-on-year change?
- What is Compass Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Compass Therapeutics?
- What is Compass Therapeutics quarterly CFF year-on-year change?
- What is Compass Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Compass Therapeutics?
- What is Compass Therapeutics TTM CFF year-on-year change?
What is Compass Therapeutics annual cash flow from financing activities?
The current annual CFF of CMPX is $17.34 M
What is the all time high annual CFF for Compass Therapeutics?
Compass Therapeutics all-time high annual cash flow from financing activities is $118.61 M
What is Compass Therapeutics annual CFF year-on-year change?
Over the past year, CMPX annual cash flow from financing activities has changed by +$14.40 M (+490.73%)
What is Compass Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CMPX is -$94.00 K
What is the all time high quarterly CFF for Compass Therapeutics?
Compass Therapeutics all-time high quarterly cash flow from financing activities is $124.24 M
What is Compass Therapeutics quarterly CFF year-on-year change?
Over the past year, CMPX quarterly cash flow from financing activities has changed by -$17.53 M (-100.54%)
What is Compass Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CMPX is $17.34 M
What is the all time high TTM CFF for Compass Therapeutics?
Compass Therapeutics all-time high TTM cash flow from financing activities is $124.24 M
What is Compass Therapeutics TTM CFF year-on-year change?
Over the past year, CMPX TTM cash flow from financing activities has changed by -$2.99 M (-14.70%)